Tag: Tobira

Allergan, Novartis sign NASH clinical trials pact

by Selina McKee | Apr 19, 2017 | News | 0

Allergan is expanding its research and development programme on non-alcoholic steatohepatitis (NASH) through a collaboration with Novartis that will test a new combination therapy approach for the condition.

Allergan buys Tobira for up to $1.7bn

by Selina McKee | Sep 21, 2016 | News | 0

Ireland-based Allergan is buying US biotech Tobira Therapeutics in a deal potentially worth up to $1.7 billion, as well as Akarna Therapeutics in a deal worth at least $50 million, securing itself access to a batch of experimental therapies for nonalcoholic steatohepatitis (NASH).